Intelligent Bio Solutions (INBS) Debt to Equity (2020 - 2024)
Intelligent Bio Solutions has reported Debt to Equity over the past 5 years, most recently at $0.01 for Q1 2024.
- Quarterly results put Debt to Equity at $0.01 for Q1 2024, down 82.78% from a year ago — trailing twelve months through Mar 2024 was $0.01 (down 82.78% YoY), and the annual figure for FY2023 was $0.11, down 74.79%.
- Debt to Equity for Q1 2024 was $0.01 at Intelligent Bio Solutions, down from $0.07 in the prior quarter.
- Over the last five years, Debt to Equity for INBS hit a ceiling of $0.43 in Q2 2022 and a floor of -$0.98 in Q2 2020.
- Median Debt to Equity over the past 5 years was $0.04 (2020), compared with a mean of $0.02.
- Biggest five-year swings in Debt to Equity: tumbled 95.87% in 2021 and later skyrocketed 48710.75% in 2022.
- Intelligent Bio Solutions' Debt to Equity stood at $0.02 in 2020, then tumbled by 95.87% to $0.0 in 2021, then skyrocketed by 5107.82% to $0.05 in 2022, then surged by 48.11% to $0.07 in 2023, then tumbled by 81.32% to $0.01 in 2024.
- The last three reported values for Debt to Equity were $0.01 (Q1 2024), $0.07 (Q4 2023), and $0.25 (Q3 2023) per Business Quant data.